Cassava Sciences

(NASDAQ) SAVA

Current Price$1.20

Market Cap$57.97M

Since IPO (2000)-99%

5 Year-97%

1 Year-34%

1 Month-27%

Cassava Sciences Financials at a Glance

Market Cap

$57.97M

Revenue (TTM)

$0.00

Net Income (TTM)

$77.90M

EPS (TTM)

$-1.61

P/E Ratio

-0.74

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Price

$1.20

Volume

2,373.893

Open

$1.26

Price

$1.20

Volume

2,373.893

Open

$1.26

Previous Close

$1.20

Daily Range

$1.20 - $1.27

52-Week Range

$1.20 - $4.98

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Price

$1.20

Volume

2,373.893

Open

$1.26

Previous Close

$1.20

Daily Range

$1.20 - $1.27

52-Week Range

$1.20 - $4.98

SAVA News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cassava Sciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Richard Jon Barry

Website

www.cassavasciences.com

Headquarters

Austin, TX 78731, US

SAVA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-80%

Return on Capital

-1%

Return on Assets

-72%

Earnings Yield

-1.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$57.97M

Shares Outstanding

48.31M

Volume

2.37K

Avg. Volume

527.03K

Financials (TTM)

Gross Profit

$936.00K

Operating Income

$95.39M

EBITDA

$94.45M

Operating Cash Flow

$32.25M

Capital Expenditure

$581.00K

Free Cash Flow

$32.83M

Cash & ST Invst.

$95.50M

Total Debt

$0.00

Cassava Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$57.97M

N/A

Market Cap/Employee

$1.93M

N/A

Employees

N/A

Net Income

$10.33M

+55.9%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$86.57M

-26.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-71.89%

N/A

Return on Invested Capital

-1.20%

N/A

Free Cash Flow

$8.88M

+21.7%

Operating Cash Flow

$8.88M

+21.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RANIRani Therapeutics Holdings, Inc.

RANIRani Therapeutics Holdings, Inc.$1.10+2.80%

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.$1.64+0.61%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.68-1.18%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.04-2.18%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.90+0.00%

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$10.55-9.13%

NKTXNkarta, Inc.

NKTXNkarta, Inc.$3.28+3.14%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WOKWork Medical Technology Group Ltd

WOKWork Medical Technology Group Ltd$6.66+0.70%

INTCIntel

INTCIntel$120.61-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.96-0.05%

NOKNokia

NOKNokia$13.17-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.96-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.31+0.03%

IRENIren

IRENIren$56.56+0.03%

Questions About SAVA

What is the current price of Cassava Sciences?

Cassava Sciences is trading at $1.20 per share.

What is the 52-week range for Cassava Sciences?

Over the past 52 weeks, Cassava Sciences has traded between $1.20 and $4.98.

How much debt does Cassava Sciences have?

As of the most recent reporting period, Cassava Sciences reported total debt of N/A.

How much cash does Cassava Sciences have on hand?

Cassava Sciences reported $86.57M in cash and cash equivalents in its most recent financial results.

What is Cassava Sciences’s dividend yield?

Cassava Sciences does not currently have a dividend yield.

Cassava Sciences

Cassava Sciences Financials at a Glance

SAVA News

Cassava Sciences Posts Q2 Loss on Pivot

Why Cassava Sciences Stock Dived by Almost 11% Today

Why Cassava Sciences Stock Is Skyrocketing Today

Why Cassava Sciences Stock Is Sinking Today

Is There Any Hope for Cassava Sciences Stock?

Why Cassava Sciences Stock Zoomed 21% Higher This Week

Why Cassava Sciences Stock Soared Today

1 Big Red Flag to Fear When a Stock Is Down

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cassava Sciences

SAVA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cassava Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SAVA

What is the current price of Cassava Sciences?

What is the 52-week range for Cassava Sciences?

How much debt does Cassava Sciences have?

How much cash does Cassava Sciences have on hand?

What is Cassava Sciences’s dividend yield?

Premium Investing Services